查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611167

肌腱炎治疗的全球市场规模、份额和趋势分析报告：按治疗、症状、地区和细分市场进行预测（2025-2030）

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

肌腱炎治疗市场的成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球肌腱炎治疗市场规模将达2,818亿美元，2025年至2030年复合年增长率为3.1%。

身体活动和体育活动参与的增加对运动相关伤害发生率的增加有直接影响。此外，预计工业事故发生率的上升将有助于预测期内该行业的发展和成长。世界上不断增长的老年人口也更容易患骨病、糖尿病、关节炎、骨关节炎、骨质疏鬆症或肌腱炎。不断创新先进的治疗方法和技术来管理肌腱炎的市场参与企业也为市场的成长做出了贡献。

投资增加、产业联盟和政府支持加强也是加速市场成长的主要因素。在过去的几年里，运动员的医疗保健已经从积极治疗方法，治疗方法防止受伤。根据标准儿童健康的数据，2018年，美国参与体育活动的3,000万青少年中，约有350万人遭受了与运动相关的伤害。根据研究，美国每年约有775,000名青少年接受运动相关伤害的治疗或治疗。

在 COVID-19 大流行期间以及各国实施封锁和旅行限制期间，由于肌腱炎治疗数量的减少，行业增长受到了负面影响。体育赛事的延后和取消导致运动相关伤害发生率下降，导致市场表现下滑。 2021年，治疗领域占最大份额，预计在预测期内将大幅成长。这是因为非侵入性治疗方法是首选。治疗管理的第一线是物理治疗，预计将显着成长。

跟腱炎细分市场在 2022 年占据产业主导地位。这种增长是由于运动员中与运动相关的伤害发生率增加所致。根据研究，跟腱炎的发生率为每10万人中5至10人。由于知名製造商和分销商的存在、运动相关伤害和创伤发生率的增加以及人们对各种疗法和外科手术的可用性的认识不断增强，北美在 2022 年占据了最大份额。

肌腱炎治疗市场报告亮点

  • 按治疗方式来看，治疗细分市场在 2024 年占据了最大的收益占有率，并在肌腱炎治疗行业中占据主导地位。肌腱炎患者对非侵入性治疗的日益偏好促进了这一领域的成长。
  • 按症状划分，跟腱炎细分市场占据主导地位，2024 年销售份额为 48.8%。由于跟腱炎的高发病率，尤其是运动员和从事重复性体力活动的人，该细分市场占据了市场主导地位。
  • 北美肌腱炎治疗市场占据主导地位，2024 年收益占有率为 42.2%。该地区肌腱炎手术数量的增加和消费者可支配收入水准的上升对该地区的成长做出了贡献。
  • 由于人口迅速老化、肌肉骨骼健康意识不断增强以及医疗保健投资不断增加等综合因素，预计亚太地区在预测期内将见证肌腱炎治疗市场的最快增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章肌腱炎治疗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 配套市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 法律规范
  • 肌腱炎治疗：市场分析工具
    • 产业分析：波特五力分析
    • PESTLE分析

第四章肌腱炎治疗细分市场分析：依治疗类型（2018-2030）

  • 定义和范围
  • 治疗市场占有率分析（2024/2030）
  • 细分仪表板
  • 全球肌腱炎治疗市场：依治疗分类（2018-2030）
  • 治疗
    • 治疗市场估计与预测（2018-2030）
    • 热疗和冷疗
    • 物理治疗
    • 衝击波疗法
  • 外科手术
    • 手术市场估计与预测（2018-2030）

第五章肌腱炎治疗细分市场分析：依症状（2018-2030）

  • 定义和范围
  • 症状市场占有率分析（2024/2030）
  • 细分仪表板
  • 全球肌腱炎治疗市场：依症状分类（2018-2030）
  • 网球肘
    • 网球肘的市场估计与预测（2018-2030）
  • 高尔夫球肘
    • 高尔夫球肘的市场估计与预测（2018-2030）
  • 棒球肘
    • 棒球肘市场估计与预测（2018-2030）
  • 跳膝
    • 跳绳膝盖市场估计与预测（2018-2030）
  • 游泳肩膀
    • 游泳肩市场估计与预测（2018-2030）
  • 跟腱炎
    • 跟腱炎市场估计与预测（2018-2030）

第六章肌腱炎治疗细分市场分析：按地区（2018-2030）

  • 区域市场占有率分析（2024/2030）
  • 区域市场仪表板
  • 区域市场简介
  • 肌腱炎治疗市场占有率：按地区（2024/2030）
  • 北美洲
    • 北美肌腱炎治疗市场（2018-2030）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲肌腱炎治疗市场（2018-2030）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司简介
    • Merck and Co., Inc.
    • Bayer AG
    • AstraZeneca
    • Boehringer Ingelheim Pharmaceuticals, Inc.
    • Abbott
    • Pfizer
    • GlaxoSmithKline PLC
    • Almatica Pharma, Inc.
    • Teva Pharmaceuticals Industries
Product Code: GVR-4-68039-530-4

Tendonitis Treatment Market Growth & Trends:

The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children's Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2022. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2022 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

Tendonitis Treatment Market Report Highlights:

  • By treatment, the therapy segment dominated the tendonitis treatment industry with the largest revenue share in 2024. The increasing preference of patients with tendonitis for non-invasive treatments contributes to segment growth.
  • By condition, the Achilles tendonitis segment dominated the market with a revenue share of 48.8% in 2024. The segment dominated the market due to the high incidence of Achilles tendonitis condition, particularly among athletes and individuals engaged in repetitive physical activities.
  • North America tendonitis treatment market dominated with a revenue share of 42.2% in 2024. A growing number of surgeries performed for tendonitis in the region and increasing consumer disposable income levels are among the few factors that contribute to the region's growth.
  • The Asia Pacific region is expected to witness the fastest growth in the tendonitis treatment market over the forecast period, driven by a combination of factors such as a large and rapidly aging population, increased awareness about musculoskeletal health, and rising healthcare investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Condition outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tendonitis Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Regulatory Framework
  • 3.4. Tendonitis Treatment: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Tendonitis Treatment Market Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Treatment Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tendonitis Treatment Market, by Treatment, 2018 to 2030
  • 4.5. Therapy
    • 4.5.1. Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Hot and Cold Therapy
      • 4.5.2.1. Hot and Cold Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Physical Therapy
      • 4.5.3.1. Physical therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Shockwave Therapy
      • 4.5.4.1. Shockwave Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Surgery
    • 4.6.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Tendonitis Treatment Market Segment Analysis, By Condition, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Condition Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tendonitis Treatment Market, by Condition, 2018 to 2030
  • 5.5. Tennis elbow
    • 5.5.1. Tennis elbow market estimates and forecasts, 2018 to 2030 (USD million)
  • 5.6. Golfer's elbow
    • 5.6.1. Golfer's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Pitcher's elbow
    • 5.7.1. Pitcher's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Jumper's Knee
    • 5.8.1. Jumper's Knee market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Swimmer's shoulder
    • 5.9.1. Swimmer's shoulder market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Achilles Tendonitis
    • 5.10.1. Achilles tendonitis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Tendonitis Treatment Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Tendonitis Treatment Market Share by Region, 2024 & 2030:
  • 6.5. North America
    • 6.5.1. North America tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Canada tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Mexico tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. UK tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Germany tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. France tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Italy tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Spain tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Norway tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Sweden tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Denmark tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Japan tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. China tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. India tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Australia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Thailand tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Brazil tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Argentina tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. South Africa tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Saudi Arabia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. UAE tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Kuwait tendonitis treatment market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Merck and Co., Inc.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Bayer AG
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. AstraZeneca
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Boehringer Ingelheim Pharmaceuticals, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Pfizer
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. GlaxoSmithKline PLC
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Almatica Pharma, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Teva Pharmaceuticals Industries
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Product pipeline/clinical stage
  • Table 4. List of emerging companies in tendonitis treatment market
  • Table 5. North America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7. North America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 8. U.S. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9. U.S. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 10. Canada Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 12. Mexico Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13. Mexico Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 14. Europe Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16. Europe Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 17. U.K. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18. U.K. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 19. Germany Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20. Germany Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 21. France Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. France Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 23. Spain Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. Spain Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 25. Italy Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26. Italy Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 27. Norway Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. Norway Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 29. Denmark Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Denmark Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 31. Sweden Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32. Sweden Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 36. China Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. China Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 38. Japan Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 39. Japan Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 40. India Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. India Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 42. Australia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Australia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 44. South Korea Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. South Korea Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 46. Thailand Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. Thailand Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 48. Latin America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 50. Latin America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million
  • Table 51. Brazil Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 52. Brazil Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 53. Argentina Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54. Argentina Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 55. MEA Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 57. MEA Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 58. South Africa Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 59. South Africa Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 62. UAE Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63. UAE Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 64. Kuwait Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Tendonitis Treatment Market snapshot (2022)
  • Fig. 11 Tendonitis Treatment Market segmentation
  • Fig. 12 Market trends and outlook
  • Fig. 13 Parent market outlook
  • Fig. 14 Related/ancillary market outlook
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Tendonitis Treatment Market, treatment outlook: key takeaways (USD Million)
  • Fig. 18 Tendonitis Treatment Market: treatment movement analysis, 2022 & 2030 (USD Million)
  • Fig. 19 Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 20 Hot and Cold Treatment Market 2018 - 2030 (USD Million)
  • Fig. 21 Physical Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 22 Shockwave Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 23 Surgery Treatment Market 2018 - 2030 (USD Million)
  • Fig. 24 Tendonitis Treatment Market, Condition outlook: key takeaways (USD Million)
  • Fig. 25 Tendonitis Treatment Market: Condition movement analysis, 2022 & 2030 (USD Million)
  • Fig. 26 Tennis Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Golfer's Elbow market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 28 Pitcher's Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Jumper's Knee market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Swimmer's Shoulder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Achilles Tendonitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Tendonitis Treatment Market, regional marketplace: Key takeaways (USD Million)
  • Fig. 33 Tendonitis Treatment Market: regional movement analysis, 2022 & 2030 (USD Million)
  • Fig. 34 North America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 MEA Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)